Ionis Pharmaceuticals | IONS - Ordinary Share Capital

Stock Price
71.19
Daily Change
-1.15 -1.59%
Monthly
-12.50%
Yearly
115.99%
Q1 Forecast
69.04

Ionis Pharmaceuticals reported $161.97M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
Astellas Pharma JPY 1.79B 195K Dec/2025
BioCryst Pharmaceuticals USD 1.9M 3K Sep/2023
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Celltrion KRW 218.78M 1.5M Sep/2025
Cspc Pharmaceutical CNY 11.52B 486M Jun/2025
Deva Holding AS TRY 200.02M 0 Sep/2023
Divis Laboratories Ltd INR 265.47M 264.53M Sep/2025
Esperion Therapeutics USD 112K 11K Sep/2023
Exelixis USD 268.1M 2.03M Sep/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Kangmei Pharma CNY 13.86B 0 Jun/2025
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
Laboratorios Farma EUR 51.82M 1.55M Dec/2023
Malin Corporation EUR 200K 0 Dec/2024
Medical Developments International AUD 112.66M 2.35M Dec/2025
Moderna USD 391M 2M Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Neurocrine Biosciences USD 100.1M 400K Dec/2025
Novartis USD 1.94B 23.4M Jun/2025
Omeros USD 611K 17K Dec/2023
OPKO Health USD 768.7M 761.69M Sep/2025
Organigram Holdings CAD 134.46M 438.86K Sep/2025
Ovoca Bio EUR 11.06M 0 Jun/2022
Pfizer USD 5.69B 1000K Sep/2025
Pharma Mar EUR 17.36M 214.99K Dec/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Qiagen NV USD 216.56M 284.67K Dec/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
Sartorius EUR 69.04M 0 Sep/2025
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
Tilray USD 1.06B 86.93M Mar/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
Vertex Pharmaceuticals USD 254M 0 Dec/2025
Zz Pientze Pharmaceu CNY 603.32M 0 Sep/2025